Holmium laser technologies versus photoselective greenlight vaporization for patients with benign prostatichyperplasia: a meta-analysis

This study aims to compare the efficacy and safety of holmium laser technologies (HoL-Ts) and photoselective greenlight vaporization (PVP) for the treatment of benign prostatic hyperplasia (BPH), and to perform a meta-analysis according to the Preferred Reporting Items of Systematic Reviews and Meta-Analyses guidelines on PubMed, EMBASE, ClinicalTrial.gov, and the Cochrane Central Register of Controlled Trials up to August 2019. Functional outcomes, perioperative parameters, and complications were included and analyzed. Review Manager 5.3 (Cochrane Collaboration, Oxford, UK) was used to perform all analyses. A total of six articles composed of 2014 patients were included in this review. In comparison with PVP, HoL-Ts had a better performance in 1-, 3-, and 6-month Qmax (P = 0.02, butI2 = 81%), with less postvoid residual urine volume (PVR) (MD = −33.85, 95% CI −52.13 to −15.57,P = 0.0003) and less total energy used (MD = −31.66, 95% CI −58.99 to −4.33,P = 0.02). Moreover, HoL-Ts had a relatively lower risk of conversion rate (OR = 0.08, 95% CI 0.01 to 0.60,P = 0.01) associated with enough enucleation and less intraoperative bleeding. Subgroup analysis of holmium laser enucleation of prostate (HoLEP) versus PVP suggested that HoLEP presented better results in 1-, 3-, 6-month and 1-year Qmax with less PVR, less energy consumption, and lower c...
Source: Lasers in Medical Science - Category: Laser Surgery Source Type: research

Related Links:

To evaluate the efficacy of prostatic artery coil embolization for hematuria related to benign-prostate hyperplasia, radiation therapy, or traumatic Foley catheter placement or removal.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Scientific Session 37 Source Type: research
Authors: Dominique I, Ecochard R, Morel-Journel N, Terrier JE, Paparel P, Ruffion A, Champetier D Abstract INTRODUCTION: Preoperative information is a key to adherence to treatment for the patients, but may be misunderstood because of its density and complexity. The aim of this study was to assess comprehension and satisfaction of patients about preoperative information of benign prostatic hyperplasia (BPH) surgery. Factors influencing patient understanding were also studied. PATIENTS AND METHODS: It was a monocentric study on questionnaires including every patients planned for BPH surgery, whatever the surgica...
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
By AMY KRAMBECK, MD The trend toward less invasive procedures, shifting from inpatient to outpatient, has changed the face of surgery. Industry-changing leaps in technology and surgical techniques have allowed us to achieve our treatment goals with smaller incisions, laparoscopy and other “closed” procedures, less bleeding, less pain, and lower complication rates. As a result, patients who used to require days of recovery in the hospital for many common surgeries can now recuperate in their own homes. Outpatient procedures grew from about 50% to 67% of hospitals’ total surgeries between 1994 and 20...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Medical Practice Physicians Amy Krambeck benign prostatic hyperplasia outpatient surgery Source Type: blogs
ConclusionsbPAE is as effective as cPAE in treating benign prostatic hyperplasia with a potential to reduce nontarget embolization.
Source: Journal of Vascular and Interventional Radiology - Category: Radiology Source Type: research
The objective of this article is to detail our surgical approach to the anatomic GreenLight laser vaporization-incision technique using the XPS LBO-180W system, based on extensive personal experience with both enucleation and vaporization techniques using various laser technologies. Standardization of the VIT based on proper cystoscopy, knowledge of prostate anatomy with preoperative ultrasound, and routine technique is essential to developing consistent, reproducible and optimal surgical outcomes. PMID: 31629449 [PubMed - in process]
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research
ConclusionsbPAE is as effective as cPAE in treating benign prostatic hyperplasia with a potential to reduce nontarget embolization.
Source: Journal of Vascular and Interventional Radiology - Category: Radiology Source Type: research
ConclusionsHistorical ethnobotanical investigations could help to avoid creating repeating waves of popularity of plants that have already been tried for certain diseases and later abandoned as not fully effective. There is, of course, a chance that E. angustifolium could also finally be proven to be clinically safe and cost-effective for treating benign prostatic hyperplasia, but this has not yet happened despite recent intensive research. Documented traditional use would suggest investigating the dermatological, intestinal anti-hemorrhagic and pain inhibiting properties of this plant, if any.Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
In this study, we compared results of bipolar TURP using the resection loop versus vaporization button for treatment of benign prostatic hyperplasia (BPH) to determine the relative safety profile.Patients and methodsBetween January 2013 and March 2014, 89 patients with BPH were randomized to surgical intervention either by Olympus (Gyrus) Bipolar loop TURP or Olympus (Gyrus) Bipolar button vaporization. Inclusion criteria were; BPH with Q-max    18 and prostate volume >  40 g. All patients were evaluated preoperatively and at 1, 3 and 9 months. Evaluation included IPSS, uroflowmetry, pro...
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
AbstractBackgroundThe continuous intake of antithrombotic drugs during holmium laser enucleation of the prostate (HoLEP) remains nonconsensual. We aim to pool those controversial evidence and provide practical guidance of oral antithrombotics on HoLEP for benign prostate hyperplasia (BPH).MethodPubMed, Embase and CENTRAL database were systematically searched up to June 2019 for trials on patients with and without oral antithrombotics undergoing HoLEP. Number of events and mean value with standard deviation were, respectively, extracted for dichotomous and continuous parameters. Subgroup analyses of anticoagulation and anti...
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
Obsidio Inc., a medical device company based in Columbia, South Carolina, has developed an embolic hydrogel (called a gel embolic material: GEM) designed to be delivered minimally invasively through a clinical catheter for blood vessel occlusion. App...
Source: Medgadget - Category: Medical Devices Authors: Tags: Cardiac Surgery Exclusive Neurosurgery Oncology Vascular Surgery Source Type: blogs
More News: Benign Prostatic Hyperplasia | Biomedical Science | Bleeding | Laser Surgery | Science | Study